<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Pediatrics</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatrics</journal-id>
<journal-id journal-id-type="hwp">pediatrics</journal-id>
<journal-id journal-id-type="pmc">pediatrics</journal-id>
<journal-id journal-id-type="publisher-id">Pediatrics</journal-id>
<journal-title-group>
<journal-title>Pediatrics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0031-4005</issn>
<issn pub-type="epub">1098-4275</issn>
<publisher>
<publisher-name>American Academy of Pediatrics</publisher-name>
<publisher-loc>Elk Grove Village, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26438699</article-id>
<article-id pub-id-type="pmc">4621800</article-id>
<article-id pub-id-type="publisher-id">peds.2015-1807</article-id>
<article-id pub-id-type="doi">10.1542/peds.2015-1807</article-id>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>25.00</subject>
<subject>37.00</subject>
<subject>37.01</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Incidence of Dravet Syndrome in a US Population</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wu</surname>
<given-names>Yvonne W.</given-names>
</name>
<degrees>MD</degrees>
<degrees>MPH</degrees>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sullivan</surname>
<given-names>Joseph</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McDaniel</surname>
<given-names>Sharon S.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Meisler</surname>
<given-names>Miriam H.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff6">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Walsh</surname>
<given-names>Eileen M.</given-names>
</name>
<degrees>RN</degrees>
<degrees>MPH</degrees>
<xref ref-type="aff" rid="aff4">
<sup>e</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Sherian Xu</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="aff4">
<sup>e</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kuzniewicz</surname>
<given-names>Michael W.</given-names>
</name>
<degrees>MD</degrees>
<degrees>MPH</degrees>
<xref ref-type="aff" rid="aff4">
<sup>e</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>f</sup>
</xref>
</contrib>
<aff id="aff1">Departments of <sup>a</sup>Neurology and</aff>
<aff id="aff2"><sup>b</sup>Pediatrics, University of California, San Francisco, San Francisco, California;</aff>
<aff id="aff3">Divisions of <sup>c</sup>Child Neurology,</aff>
<aff id="aff4"><sup>e</sup>Research, and</aff>
<aff id="aff5"><sup>f</sup>Neonatology, Kaiser Permanente Northern California, Oakland, California; and</aff>
<aff id="aff6"><sup>d</sup>Department of Human Genetics, University of Michigan, Ann Arbor, Michigan</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">Address correspondence to Yvonne W. Wu, MD, MPH, Department of Neurology, University of California, San Francisco, 675 Nelson Rising Ln, Suite 411, Box 0663, San Francisco, CA 94143. E-mail: <email>wuy@ucsf.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>11</month>
<year>2015</year>
</pub-date>
<volume>136</volume>
<issue>5</issue>
<fpage>e1310</fpage>
<lpage>e1315</lpage>
<history>
<date date-type="accepted">
<day>12</day>
<month>8</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2015 by the American Academy of Pediatrics</copyright-statement>
<copyright-year>2015</copyright-year>
</permissions>
<self-uri xlink:href="peds.2015-1807.pdf" xlink:title="pdf" xlink:type="simple"></self-uri>
<abstract>
<sec>
<title>OBJECTIVE:</title>
<p>De novo mutations of the gene sodium channel 1α (<italic>SCN1A</italic>) are the major cause of Dravet syndrome, an infantile epileptic encephalopathy. US incidence of DS has been estimated at 1 in 40 000, but no US epidemiologic studies have been performed since the advent of genetic testing.</p>
</sec>
<sec>
<title>METHODS:</title>
<p>In a retrospective, population-based cohort of all infants born at Kaiser Permanente Northern California during 2007–2010, we electronically identified patients who received ≥2 seizure diagnoses before age 12 months and who were also prescribed anticonvulsants at 24 months. A child neurologist reviewed records to identify infants who met 4 of 5 criteria for clinical Dravet syndrome: normal development before seizure onset; ≥2 seizures before age 12 months; myoclonic, hemiclonic, or generalized tonic-clonic seizures; ≥2 seizures lasting &gt;10 minutes; and refractory seizures after age 2 years. <italic>SCN1A</italic> gene sequencing was performed as part of routine clinical care.</p>
</sec>
<sec>
<title>RESULTS:</title>
<p>Eight infants met the study criteria for clinical Dravet syndrome, yielding an incidence of 1 per 15 700. Six of these infants (incidence of 1 per 20 900) had a de novo <italic>SCN1A</italic> missense mutation that is likely to be pathogenic. One infant had an inherited <italic>SCN1A</italic> variant that is unlikely to be pathogenic. All 8 experienced febrile seizures, and 6 had prolonged seizures lasting &gt;10 minutes by age 1 year.</p>
</sec>
<sec>
<title>CONCLUSIONS:</title>
<p>Dravet syndrome due to an <italic>SCN1A</italic> mutation is twice as common in the United States as previously thought. Genetic testing should be considered in children with ≥2 prolonged febrile seizures by 1 year of age.</p>
</sec>
</abstract>
<counts>
<page-count count="6"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>